Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2017

View Archived Issues

Immunovaccine announces achievement in personalized cancer vaccine program

hKCC2 found as a novel target in traumatic brain injury

Vifor Pharma begins three studies in iron deficiency and heart failure

E-Scape Bio closes series A financing extension

OncoTherapy Science announces a new subsidiary company

Bayer tests novel thrombin inhibitor BAY-224 in thrombosis models

Sunovion sells U.S. rights to ciclesonide products to Covis Pharma

New mutations in F13B gene tied to mild FXIII deficiency

Viamet Pharmaceuticals wins FDA fast track designation for VT-1598

FDA accepts Pfizer's sNDA for Xeljanz in ulcerative colitis

Encouraging phase IIa results for DMX-200 in patients with proteinuria

Neuroprotective effects of co-ultraPEALut explored in model of vascular dementia

Gilead Sciences' MAA for bictegravir/emtricitabine/tenofovir alafenamide FDC validated by EMA

Chengdu Baiyu Ginkgolide Pharmaceuticals divulges ginkgolide B derivatives

Southern Research Institute identifies LRRK2 inhibitors

ShangPharma Innovation enters collaboration with UCSF

Raze Therapeutics discloses MTHFD2 inhibitors

Bioelectron Technology discloses hydroquinone derivatives for neurodegeneration

Bristol-Myers Squibb discovers CXCR4 antagonists

Aduro BioTech earns milestone in Merck & Co. collaboration

Tulane University receives grants from NIH to create Lassa vaccine and treatment

FDA agrees to add indication to Apexian Pharmaceuticals' IND for APX-3330

Mirikizumab named orphan drug for pediatric Crohn's disease in the U.S.

FDA approves Tremfya for moderate to severe plaque psoriasis

RNS-60 receives FDA orphan designation for amyotrophic lateral sclerosis

Novel ITGA2B gene mutations found in Glanzmann thrombasthenia

EMA validates pacritinib MAA for patients with myelofibrosis who have thrombocytopenia

FDA grants fast track designation to SB-318 and SB-913

MMRF selects Avista Pharma to manufacture component of opioid addiction vaccine

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...